Influence of Lipid Class Used for Omega-3 Fatty Acid Supplementation on Liver Fat Accumulation in MASLD - Sabinari, I; Horakova, O; Cajka, T; Kleinova, V; Wieckowski, MR; Rossmeisl, M (Physiological research, 2024)
Keywords: Animal models; Animals; Bioavailability; Body weight loss; Comparative studies; Diet; Dietary Supplements; Eicosapentaenoic acid; Energy metabolism; Esters; Fat metabolism; Fatty acids; Fatty Acids, Omega-3 - administration & dosage; Fatty Acids, Omega-3 - metabolism; Fatty Acids, Omega-3 - therapeutic use; Fatty liver; Fatty Liver - drug therapy; Fatty Liver - metabolism; Fish oils; Hepatocytes; Human subjects; Humans; Lipid metabolism; Lipid Metabolism - drug effects; Lipids; Liver - drug effects; Liver - metabolism; Liver - pathology; Liver diseases; Metabolic syndrome; Mortality; Non-alcoholic Fatty Liver Disease - diet therapy; Non-alcoholic Fatty Liver Disease - drug therapy; Non-alcoholic Fatty Liver Disease - metabolism; Non-alcoholic Fatty Liver Disease - pathology; Obesity; Obesity - diet therapy; Obesity - drug therapy; Obesity - metabolism; Obesity - pathology; Oils & fats; Omega-3 fatty acids; Phospholipids; Polyunsaturated fatty acids; Review; Steatosis; Supplements; Weight control